Zali, Alireza <br/><br/>
Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety.  [electronic resource] 

 -  Cytotherapy  Feb 2015 
 - 232-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-2566 
<br/><br/><label>Standard No.: </label>10.1016/j.jcyt.2014.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Antigens, CD--metabolism<br/>Bone Marrow Cells<br/>Cell- and Tissue-Based Therapy--methods<br/>Cerebral Palsy--therapy<br/>Child<br/>Child, Preschool<br/>Female<br/>Glycoproteins--metabolism<br/>Hematopoietic Stem Cells<br/>Humans<br/>Injections, Spinal<br/>Male<br/>Mesenchymal Stem Cell Transplantation--adverse effects<br/>Mesenchymal Stem Cells--cytology<br/>Motor Skills--physiology<br/>Muscle Spasticity--therapy<br/>Peptides--metabolism<br/>Safety